vimarsana.com

Page 38 - ஜொல்லா நிறுவனம் க்கு நோயெதிர்ப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications News provided by Share this article Share this article LOS ANGELES, May 11, 2021 /PRNewswire/ Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced its launch from stealth backed by $52 million Series A financing led by 8VC. Other investors included Two Sigma Ventures, among others, and participation from seed investors Sherpa Healthcare Partners and Freeflow Ventures.

More than a year into the pandemic, we re still figuring out what risks we re willing to take

Vaccines for kids are coming Here s what that might mean for your family

Vaccines for kids are coming. Here’s what that might mean for your family. Claire Trageser © Photograph courtesy of Cincinnati Children s Hospital A 12-year-old boy participates in Pfizer s COVID-19 vaccine trial at Cincinnati Children s Hospital Medical Center last year. Updated May 11, 2021, following the FDA announcement authorizing the Pfizer-BioNTech coronavirus vaccine for emergency use in 12- to 15-year-olds. Julia Olmstead knows her son Brodie has not had the year most teenagers dream about. Instead of the newfound independence teens often have, he’s had the exact opposite. “This whole year he’s been forced to be with his family 24 hours a day,” says Olmstead, who lives in St. Paul. “We’ve been super strict about COVID precautions. All winter he didn’t see any friends.”

How well are we protected six months after infection or vaccination?

How well are we protected six months after infection or vaccination? Researchers are gaining a better understanding of how long a passed infection or vaccination protects against the virus. The latest findings are rather reassuring, also with regard to the virus variants. How long and how well does the human immune system remember an encounter with SARS-CoV-2 or an encounter with at least fragments of the virus, as occurs with vaccination? One year? Two years? And how well is one still protected from infection with the coronavirus during that time? Carlos A. Guzmán heads the Department of Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig (Image: HZI).

ARCS San Diego honors 2021 Scientist of the Year at virtual event

ARCS San Diego honors 2021 Scientist of the Year at virtual event April 24, 2021 4:11 PM PT Print Each year ARCS San Diego, a local nonprofit led entirely by women, hosts a Scientist of the Year fundraiser, which honors a preeminent local scientist. Due to the coronavirus pandemic, the 2021 ARCS Scientist of the Year (SOY) event will be presented once again online. Mark your calendars for Sunday, April 25 (6-7:15 p.m.) when the event will be streamed live via YouTube. Erica Ollmann Saphire, PhD (Courtesy) ARCS San Diego has put together an exciting program for its signature SOY event that will highlight 46 scholars, several scholar alumni, and the 2021 Scientist of the Year: Dr. Erica Ollmann Saphire, professor at the La Jolla Institute for Immunology, and one of the world’s leading experts in pandemic and emerging viruses.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.